February 03, 2012
On February 1, 2012, Pfizer announced that it is recalling 1 million packages of its Lo/Ovral-28 tablets and generic Norgestrel and Ethinyl Estradiol tablets, because some of the birth control tablets may be out of sequence, or there may be more of the active pills in some packages and more inactive pills in other packages.
The recall notice provides:
These tablets were manufactured and packaged by Pfizer Inc., commercialized by Akrimax Rx Products and labeled under the Akrimax Pharmaceuticals brand. This product is distributed to warehouses, clinics and retail pharmacies nationwide.
Users of the birth control pills are being advised, by the FDA, to contact their doctors right away.
Practically, it is advisable that women maintain the birth control packaging as evidence and consult with an attorney to learn and secure their legal rights.
For a free consultation, feel free to contact Reza Sina at email@example.com or (213) 417-3661.
The firm’s website: Sina Law Group